Extracellular Matrix Market, By Component Type (Proteins, Glycoproteins, Proteoglycans, Other ECM molecules), By Application (Regenerative Medicine, Tissue Engineering, Wound Healing, Drug Delivery, Cancer Research, Others), By Source (Animal-Derived ECM, Human-Derived ECM, Synthetic ECM), By End-User (Research Institutes and Academic Centers, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics), By Product Type (Hydrogels, Scaffolds, Decellularized ECM, ECM Analogs, Others), By Technology (3D Bioprinting, Nanotechnology, Cell Culture Techniques, Genetic Engineering, Others), By Therapeutic Area (Orthopedics, Dermatology, Cardiology, Neurology, Oncology, Others), By Function (Structural Support, Cellular Communication, Cell Adhesion, Signal Transduction), By Biomaterial Type (Natural ECM, Synthetic ECM), By End-Use Industry (Healthcare, Research and Development, Cosmetics, Pharmaceuticals, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)